Status:

COMPLETED

The Predictive Role of Self-representation in Transition of Individuals at Clinical High Risk for Psychosis

Lead Sponsor:

Shanghai Mental Health Center

Conditions:

Clinical High Risk for Psychosis

Eligibility:

All Genders

11-45 years

Brief Summary

Schizophrenia is one of the most consumptive diseases, which brings great loss to patients and their families, and even to the society. Clinical High Risk for Psychosis (CHR) is a concept put forward ...

Detailed Description

This study is conducted according to the tenets of the Declaration of Helsinki. All participants are recruited at the Shanghai Mental Health Center (SMHC) or its affiliate, the Shanghai Psychotherapy ...

Eligibility Criteria

Inclusion

  • For CHR individuals, meet the criteria of psychosis-risk syndromes after rating by structured interview for psychosis high risk syndrome.
  • For FES patients, meet diagnostic criteria for schizophrenia in the DSM-IV.
  • For HC individuals, gender composition, age range, educational level are matched with CHR individuals.
  • Understand and sign written informed consent.

Exclusion

  • For CHR individuals, exclude individuals with other axis I or II mental disorders, which can explain the abnormal experience.
  • For CHR and FES patients, exclude those patients taking antipsychotics for more than two weeks.
  • For HC individuals, exclude those with family history of mental disorders
  • With a history of substance dependence.
  • Use of medications that may affect mental and cognitive functions.
  • With central nervous system disorder, that cuase symptoms or interfere with judgment.
  • Traumatic brain injury score is 7 or more.
  • With serious or unstable physical diseases.
  • With perceptual developmental disorders.
  • IQ\<70.

Key Trial Info

Start Date :

July 6 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

November 30 2021

Estimated Enrollment :

160 Patients enrolled

Trial Details

Trial ID

NCT04444180

Start Date

July 6 2019

End Date

November 30 2021

Last Update

January 23 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Shanghai Mental Health Center

Shanghai, Shanghai Municipality, China, 200030